The invention relates to the production of rifamycin analogs against drug resistant bacteria. The invention also relates to antibacterial compounds against drug resistant mycobacteria. The invention also provides for pharmaceutical composition comprising antibacterial compound against drug resistant bacteria, particularly mycobacteria. The invention also provides for use of antibacterial compounds for the treatment of disease caused by bacteria and in particular mycobacteria.